I Have My Protection—And It’s Not a Condom

By Blake Rowley, Manager, Health Equity & Prevention, NASTAD

Originally published by The Black AIDS Institute

Blake Rowley

Blake Rowley

Like most other Black men, I have had extremely inconsistent engagement with healthcare. If I’m not sick, why go? Until recently, the only time I really cared to access any type of care was when I was getting tested for HIV and other STIs.

In 2012, while conducting research at Fenway Health, I learned that multiple studies were trying to assess how effective taking one pill, once a day, would be at preventing HIV infection. My colleagues and I would joke about taking this pill once it became available, if it was successful. And then “BOOM,” there it was—a one-a-day pill that could prevent HIV by close to 100 percent. Continue reading

NASTAD Botswana Featured in AllAfrica

The content of this post originally appeared in AllAfrica in January 2015.

Botswana: Balosang Preaches DMSAC Message

By Eric Raphuti

Hukuntsi — Insufficient knowledge about roles and responsibilities of District Multi-Sectoral AIDS Committee (DMSAC) among relevant stakeholders is a stumbling block to execution of its mandate, says Ms Matsae Balosang, a country manager of National Alliance of State & Territorial AIDS Directors (NASTAD).

Continue reading

Silence Isn’t Safety: Bringing True Awareness to National Black HIV/AIDS Awareness Day

By Justin T. Rush, Nicholas A. Rango Fellow, NASTAD

As the Nicholas A. Rango Fellow at the National Alliance of State and Territorial AIDS Directors (NASTAD), I have the fortunate and unique opportunity to provide technical assistance to 12 health department jurisdictions on what each can be doing to respond to the high HIV incidence among Black gay men and men who have sex with men (MSM) within their localities. This means that, as it pertains to addressing the needs of Black gay men/MSM, I play a pivotal role at NASTAD in assisting state health departments with meeting those needs. Admittedly, being seen as the “go to” for Black gay men’s issues can be a bit daunting. So when I was tasked with kicking off this blog series focused on highlighting National Black HIV/AIDS Awareness Day, I had to take a step back and reflect. I had to ask myself: With an awareness day for seemingly every day of every year, what could we do to truly have an impact on HIV within the Black community? Continue reading

NASTAD at NAESM 2015: Why the Lives of Black Men Who Have Sex With Men Still Matter for Many

By Drew Daniels, Manager, Communications, NASTAD

More than 400 public health professionals, researchers and community advocates from all across the United States attended the National African American MSM Leadership Conference on HIV/AIDS and other Health Disparities sponsored by National AIDS & Education Service for Minorities (NAESM) in Atlanta, January 15-18, 2015.  With recent current events surrounding police brutality and racism, this year’s theme was “Leading the Movement: Pursuing Health Equity through Social Justice.” The conference focused on how to address health equity and utilize social justice in order to meet the challenge of improving the health of Black men who have sex with men (MSM). Continue reading

ADAP Crisis Task Force Announces Groundbreaking Agreement with AbbVie for Hepatitis C Treatment Viekira Pak™

ADAP Crisis Task Force Announces Groundbreaking Agreement with AbbVie for Hepatitis C Treatment Viekira Pak 

FOR IMMEDIATE RELEASE
Contact:  Britten Pund
202-434-8090
bpund@NASTAD.org

AbbVieJanuary 15, 2015, Washington, DC – The ADAP Crisis Task Force (Task Force) has reached a new pricing agreement between AbbVie and AIDS Drug Assistance Programs (ADAPs) for Viekira Pak (ombitasvir/paritaprevir/ritonavir tablets; dasabuvir tablets) for the treatment of hepatitis C (HCV). AbbVie is the first company to offer a discount on the ADAP price of an HCV medication in the era of new curative HCV treatments. The agreed-upon ADAP price for Viekira Pak, negotiated between the Task Force and AbbVie, reflects voluntary discounts and rebates that are significantly lower than the wholesale acquisition cost (WAC).  While many ADAPs may not be able to add Viekira Pak to their formularies due to fiscal constraints, this agreement recognizes the importance of access to hepatitis C medications for people living with HIV and demonstrates good faith that access at a discounted price may lead to formulary inclusion. ADAPs make individual decisions about adding new medications to their formularies. Continue reading